Monitoring the Effect of Chemotherapy in a Mixed Glioma by C‐11‐Methionine PET

The effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C‐11‐methionine (C‐11‐MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow‐up at 3 years. Thus, the authors conclude that C‐11‐MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.

[1]  J. J. Heimans,et al.  Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma , 1998, Journal of Neuro-Oncology.

[2]  V. Sturm,et al.  Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy , 1996, European Journal of Nuclear Medicine.

[3]  F. Soussaline,et al.  Brain tumor protein synthesis and histological grades: A study by positron emission tomography (PET) with C11-L-Methionine , 2004, Journal of Neuro-Oncology.

[4]  M Teräs,et al.  Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. , 2000, International journal of radiation oncology, biology, physics.

[5]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Shintani,et al.  Serial positron emission tomography (PET) in gliomatosis cerebri treated with radiotherapy: a case report , 2000, Journal of the Neurological Sciences.

[7]  D. Arnold,et al.  Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. , 2000, Neurosurgery.

[8]  H Evans,et al.  Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas , 2000, British Journal of Cancer.

[9]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.

[10]  P. Black,et al.  Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. , 1998, Journal of neurosurgery.

[11]  T. Yoshimoto,et al.  Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. , 1998, Neurologia medico-chirurgica.

[12]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[13]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  D. Louis,et al.  Chemosensitive gliomas in adults: which ones and why? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  J. Slattery,et al.  Chemotherapy response criteria in malignant glioma , 1997, Neurology.

[17]  H. Herzog,et al.  3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  V. Sturm,et al.  11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. , 1997, Stereotactic and functional neurosurgery.

[19]  O. Witte,et al.  Radiation necrosis or recurrence. , 1996, Journal of neurosurgery.

[20]  M. Mehta,et al.  Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[21]  M. Bergström,et al.  Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference , 1989, Acta radiologica.

[22]  J. Cairncross,et al.  Steroid‐induced CT changes in patients with recurrent malignant glioma , 1988, Neurology.

[23]  P. Wen,et al.  Malignant gliomas , 1981, Neuro-Chirurgie.